Your browser doesn't support javascript.
loading
In Silico Human Cardiomyocyte Action Potential Modeling: Exploring Ion Channel Input Combinations.
Boulay, Emmanuel; Troncy, Eric; Jacquemet, Vincent; Huang, Hai; Pugsley, Michael K; Downey, Anne-Marie; Venegas Baca, Rafael; Authier, Simon.
Afiliación
  • Boulay E; GREPAQ (Groupe de Recherche en Pharmacologie Animale du Québec), Université de Montréal, Saint-Hyacinthe, QC, Canada.
  • Troncy E; Charles River Laboratories, Laval, QC, Canada.
  • Jacquemet V; GREPAQ (Groupe de Recherche en Pharmacologie Animale du Québec), Université de Montréal, Saint-Hyacinthe, QC, Canada.
  • Huang H; Département de Pharmacologie et Physiologie, Université de Montréal, Faculté de Médecine, Montréal, QC, Canada.
  • Pugsley MK; Centre de Recherche, Hôpital du Sacré-Cœur, Montréal, QC, Canada.
  • Downey AM; Institut de Génie Biomédical, Université de Montréal, Montréal, QC, Canada.
  • Venegas Baca R; Charles River Laboratories, Laval, QC, Canada.
  • Authier S; Toxicology & Safety Pharmacology, Cytokinetics, San Francisco, CA, USA.
Int J Toxicol ; 43(4): 357-367, 2024.
Article en En | MEDLINE | ID: mdl-38477622
ABSTRACT
In silico modeling offers an opportunity to supplement and accelerate cardiac safety testing. With in silico modeling, computational simulation methods are used to predict electrophysiological interactions and pharmacological effects of novel drugs on critical physiological processes. The O'Hara-Rudy's model was developed to predict the response to different ion channel inhibition levels on cardiac action potential duration (APD) which is known to directly correlate with the QT interval. APD data at 30% 60% and 90% inhibition were derived from the model to delineate possible ventricular arrhythmia scenarios and the marginal contribution of each ion channel to the model. Action potential values were calculated for epicardial, myocardial, and endocardial cells, with action potential curve modeling. This study assessed cardiac ion channel inhibition data combinations to consider when undertaking in silico modeling of proarrhythmic effects as stipulated in the Comprehensive in Vitro Proarrhythmia Assay (CiPA). As expected, our data highlight the importance of the delayed rectifier potassium channel (IKr) as the most impactful channel for APD prolongation. The impact of the transient outward potassium channel (Ito) inhibition on APD was minimal while the inward rectifier (IK1) and slow component of the delayed rectifier potassium channel (IKs) also had limited APD effects. In contrast, the contribution of fast sodium channel (INa) and/or L-type calcium channel (ICa) inhibition resulted in substantial APD alterations supporting the pharmacological relevance of in silico modeling using input from a limited number of cardiac ion channels including IKr, INa, and ICa, at least at an early stage of drug development.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Simulación por Computador / Potenciales de Acción / Miocitos Cardíacos / Canales Iónicos Límite: Humans Idioma: En Revista: Int J Toxicol Asunto de la revista: TOXICOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Simulación por Computador / Potenciales de Acción / Miocitos Cardíacos / Canales Iónicos Límite: Humans Idioma: En Revista: Int J Toxicol Asunto de la revista: TOXICOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos